'In-House' Professor Explains How Not Paying Doctors Puts GSK In Unique Position
Professor Paul Jones chats to Scrip about GlaxoSmithKline's new model for product communication worldwide and how it sets the company apart from its big pharma competitors.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.